Sterneck Capital Management, LLC - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 37 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Sterneck Capital Management, LLC ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q4 2021$7,000
-36.4%
25,0000.0%0.00%
-42.9%
Q3 2021$11,000
-15.4%
25,0000.0%0.01%
-12.5%
Q2 2021$13,00025,0000.01%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 903,741$497,0000.62%
Alyeska Investment Group, L.P. 5,000,000$2,750,0000.04%
WEDBUSH SECURITIES INC 97,957$54,0000.01%
SCOPUS ASSET MANAGEMENT, L.P. 225,000$124,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 60,000$33,0000.00%
683 Capital Management, LLC 42,858$24,0000.00%
UBS Group AG 600$00.00%
BNP PARIBAS FINANCIAL MARKETS 1$1,0000.00%
Advisor Group, Inc. 421$00.00%
BANK OF AMERICA CORP /DE/ 316$00.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders